small molecule

PROCHLORPERAZINE EDISYLATE

Loss of exclusivity—loss of exclusivity

CompanyNexus Labs →See this company's full patent-cliff portfolio

Drug detail

Brand name	PROCHLORPERAZINE EDISYLATE
Active ingredient	PROCHLORPERAZINE EDISYLATE
Strength	EQ 5MG BASE/ML
Dosage form	INJECTABLE
Route	INJECTION
Modality	Small molecule
FDA approval	February 2019
Marketing status	DISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.